109 related articles for article (PubMed ID: 31248723)
41. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
Ebrahimi V; Hashemi A
Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
[TBL] [Abstract][Full Text] [Related]
42. Human CRISPR.
Rusk N
Nat Methods; 2019 Aug; 16(8):677. PubMed ID: 31363223
[No Abstract] [Full Text] [Related]
43. Multiplex gene editing in rice with simplified CRISPR-Cpf1 and CRISPR-Cas9 systems.
Wang M; Mao Y; Lu Y; Wang Z; Tao X; Zhu JK
J Integr Plant Biol; 2018 Aug; 60(8):626-631. PubMed ID: 29762900
[TBL] [Abstract][Full Text] [Related]
44. The CRISPR Growth Spurt: from Bench to Clinic on Versatile Small RNAs.
Bayat H; Omidi M; Rajabibazl M; Sabri S; Rahimpour A
J Microbiol Biotechnol; 2017 Feb; 27(2):207-218. PubMed ID: 27840399
[TBL] [Abstract][Full Text] [Related]
45. Robust genome editing of CRISPR-Cas9 at NAG PAMs in rice.
Meng X; Hu X; Liu Q; Song X; Gao C; Li J; Wang K
Sci China Life Sci; 2018 Jan; 61(1):122-125. PubMed ID: 29285711
[No Abstract] [Full Text] [Related]
46. Now on Course, CRISPR J.
Newsham W
CRISPR J; 2019 Jun; 2():155-156. PubMed ID: 31225748
[No Abstract] [Full Text] [Related]
47. Thinking About CRISPR: The Ethics of Human Genome Editing.
Barrangou R
CRISPR J; 2019 Oct; 2(5):247-248. PubMed ID: 31599676
[No Abstract] [Full Text] [Related]
48. Now for the hard ones: is there a limit on CRISPR genome editing in crops?
Botella JR
J Exp Bot; 2019 Feb; 70(3):734-737. PubMed ID: 30722048
[TBL] [Abstract][Full Text] [Related]
49. Gene therapy: In vivo gene editing in non-dividing cells.
Waldron D
Nat Rev Genet; 2017 Jan; 18(1):1. PubMed ID: 27916984
[No Abstract] [Full Text] [Related]
50. Could CRISPR be the solution for gene editing's Gordian knot?
Fang H; Wang W
Cell Biol Toxicol; 2016 Dec; 32(6):465-467. PubMed ID: 27614448
[No Abstract] [Full Text] [Related]
51. A path to efficient gene editing.
Urnov FD
Nat Med; 2018 Jul; 24(7):899-900. PubMed ID: 29988144
[No Abstract] [Full Text] [Related]
52. Broadening the applicability of CRISPR/Cas9 in plants.
Puchta H
Sci China Life Sci; 2018 Jan; 61(1):126-127. PubMed ID: 29285717
[No Abstract] [Full Text] [Related]
53. CRISPR-Cas9 and Its Therapeutic Applications for Retinal Diseases.
Lin WV; Stout JT; Weng CY
Int Ophthalmol Clin; 2019; 59(1):3-13. PubMed ID: 30585915
[No Abstract] [Full Text] [Related]
54. Refining CRISPR-based genome and epigenome editing off-targets.
Luo Y
Cell Biol Toxicol; 2019 Aug; 35(4):281-283. PubMed ID: 31227932
[No Abstract] [Full Text] [Related]
55. The CRISPR-Antibiotic Resistance Connection.
Gilmore MS
CRISPR J; 2019 Aug; 2():199-200. PubMed ID: 31436505
[No Abstract] [Full Text] [Related]
56. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
57. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
58. CRISPR tool puts RNA on the record.
Beisel CL
Nature; 2018 Oct; 562(7727):347-349. PubMed ID: 30323226
[No Abstract] [Full Text] [Related]
59. Cas9 immunity creates challenges for CRISPR gene editing therapies.
Crudele JM; Chamberlain JS
Nat Commun; 2018 Aug; 9(1):3497. PubMed ID: 30158648
[TBL] [Abstract][Full Text] [Related]
60. Gene editing reveals the effect of thousands of variants in a key cancer gene.
Chanock SJ
Nature; 2018 Oct; 562(7726):201-202. PubMed ID: 30291308
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
